Welcome : Guest

Rheumatology Drugs

Abstract

This report presents Insights into the Rheumatology Drugs Market. Illustrated with 4 data tables, the report comprises of a brief statistical summarization of the worldwide market including US. Also included are global competitive player market shares.

Code: MT-00204
Price: $495
Report Type: Market Trends & Insights
Pages: 8
Date: June 2016
Market Data Tables: 4

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Rheumatology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biologicals, Coxibs, NSAIDs, TNF Inhibitors, and Others......4
Table 2: Arthritis and Rheumatic Statistics in the United States......5
Table 3: Rheumatology Drugs Market by Product Type in the US (2014) - Percentage Share Breakdown by Value Sales for Biologicals/TNF Inhibitors, Coxibs, DMARDS, Gout, MuscleRelaxants, NSAIDS, and Others......6
Table 4: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......7